Enspectra Health Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 15

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4M

  • Investors
  • 10

Enspectra Health General Information

Description

Developer of an imaging diagnostic device system designed to simplify the way physicians evaluate a broad spectrum of skin conditions. The company's device specializes in combining reflectance confocal and multiphoton laser scanning microscopy to generate real-time, multispectral images spanning wavelengths not seen with the naked eye, enabling dermatologists to improve the diagnostics and treatment of skin cancers.

Contact Information

Formerly Known As
Zebra Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2495 Hospital Drive
  • Suite 300
  • Mountain View, CA 94040
  • United States
+1 (650) 000-0000

Enspectra Health Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enspectra Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 26-May-2021 $4M 00.000 Completed Product Development
6. Grant 21-Apr-2020 00.000 00.000 Completed Product Development
5. Later Stage VC (Series A) 06-Aug-2019 00.000 00.000 000.00 Completed Product Development
4. Accelerator/Incubator 22-Jun-2018 00000 Completed Product Development
3. Grant 01-Jan-2017 00000 00000 Completed Product Development
2. Seed Round 17-Feb-2015 $700K $700K 00.000 Completed Product Development
1. Accelerator/Incubator Completed Startup
To view Enspectra Health’s complete valuation and funding history, request access »

Enspectra Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
To view Enspectra Health’s complete cap table history, request access »

Enspectra Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an imaging diagnostic device system designed to simplify the way physicians evaluate a broad spectrum of sk
Diagnostic Equipment
Mountain View, CA
15 As of 2022
00.000
0000000000 00.000

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Norcross, GA
000 As of 0000
000.00
000000000 00 000.00

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000 000000000
Sunnyvale, CA
0000 As of 0000
000.00
00 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enspectra Health Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immucor Private Equity-Backed Norcross, GA 000 000.00 000000000 00 000.00
0000000 Formerly VC-backed Sunnyvale, CA 0000 000.00 000000&0 000.00
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
000000 000000000 Formerly VC-backed Abingdon, United Kingdom 000 00000 000000&0 00000
00000000 000000000 Corporation Cincinnati, OH 000 00000000
To view Enspectra Health’s complete competitors history, request access »

Enspectra Health Patents

Enspectra Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210169336-A1 Methods and systems for identifying tissue characteristics Pending 13-Nov-2018 0000000000
US-20200196938-A1 Systems and methods for imaging and measurement of sarcomeres Pending 28-Apr-2017 0000000000
EP-3614915-A4 Systems and methods for imaging and measurement of sarcomeres Pending 28-Apr-2017 0000000000 0
EP-3614915-A1 Systems and methods for imaging and measurement of sarcomeres Pending 28-Apr-2017 0000000000
CA-3016468-A1 Non-invasive detection of skin disease Pending 08-Mar-2016 A61B5/0077
To view Enspectra Health’s complete patent history, request access »

Enspectra Health Executive Team (7)

Name Title Board Seat Contact Info
Gabriel Sanchez Ph.D Co-Founder, Chief Executive Officer & Board Member
Bill Beasley President & Chief Operating Officer
Scott Delp Ph.D Co-Founder & Board Member
Mark Schnitzer Ph.D Co-Founder
You’re viewing 4 of 7 executive team members. Get the full list »

Enspectra Health Board Members (4)

Name Representing Role Since
Gabriel Sanchez Ph.D Enspectra Health Co-Founder, Chief Executive Officer & Board Member 000 0000
Scott Delp Ph.D Self Co-Founder & Board Member 000 0000
Xuhui Shao Ph.D Foothill Ventures Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Enspectra Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enspectra Health Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Foothill Ventures Venture Capital Minority 000 0000 000000 0
Heuristic Capital Partners Venture Capital Minority 000 0000 000000 0
Social Starts Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »